Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Apr 21, 2024, 21:27 | Drugs

Hagop Kantarjian: We review the evidence leading to Tagraxofusp approval as first in class CD123-directed drug which has changed the field of BPDCN

Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X: “Tazgraxofusp is…

Apr 6, 2024, 12:48 | Positive

Naveen Pemmaraju: MD Anderson Cancer Center (MDACC) is a special place of hope and inspiration

Quoting Naveen Pemmaraju's post on LinkedIn: "When On Service: I am an Attending in the…

All: 2 Posts: 1 - 100

Dr. Richard Pazdur: 25 Years of Transforming Oncology Drug Development at the FDA

New €4.9m Beaumont RCSI Cancer Centre and Irish Cancer Society Partnership to Transform Lung Cancer Care in Ireland

Biden Cancer Moonshot Initiative Awards Over $6 Million to 11 Early-Career Researchers for Innovative Cancer Research

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Special Coverage

ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023